Search results
A new COVID variant is dominant in the US: What are its symptoms?
TODAY via Yahoo News· 4 days agoThe new "FLiRT" COVID-19 variants, including KP.3 and KP.2, are spreading in the United States. Will...
COVID-19 origins fight heads to the Senate
The Hill· 8 hours agoFauci wasn’t one of the witnesses on Tuesday, but his longtime Senate antagonist Rand Paul (R-Ky.) sharply questioned Robert F. Garry, professor at the...
Here are 7 things Arizonans need to know about the new KP.3 variant of COVID-19
The Arizona Republic via Yahoo News· 7 days agoA new variant of COVID-19 called KP.3 is on the rise in the U.S. and has been detected in Arizona. The variant of the SARS-CoV-2 < ...
Are We Headed for Another Summer COVID-19 Wave?
Time via Yahoo News· 6 days agoNationally, the amount of SARS-CoV-2 virus in wastewater is still low, according to the U.S. Centers for Disease Control ...
Covid-19 increases cardiovascular event risk in chronic respiratory patients
Clinical Trials Arena via Yahoo Finance· 23 hours agoThe second significant finding was that the severity of Covid-19 infection modified the risk of...
Hawaii-developed COVID home test kits being sold online
Honolulu Star-Advertiser· 15 hours agoA locally developed COVID-19 test kit is now on the market as cases of the contagious disease are on...
There’s A New COVID Variant, KP.3 – These Are The Symptoms
IFLScience· 4 days agoKP.3 is one of the FLiRT variants of SARS-CoV-2. The immune system can learn to recognize spike...
Past COVID infections may help protect against certain colds
WJTV Jackson· 6 days agoResearchers linked the protection against coronavirus-caused colds to virus-killing cell responses...
Past COVID-19 infection may protect people against some common colds
Euronews via Yahoo News· 6 days agoThese vaccines, he said, are “still your best defence against severe COVID-19 infection,...
US government to fund up to $500 million for studies on oral, nasal COVID vaccines
Reuters via Yahoo News· 5 days agoThe funding is part of Project NextGen, a $5 billion initiative led by the Biomedical Advanced Research and Development Authority (BARDA), to advance a pipeline of new, innovative vaccines and ...